This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Commiphora wightii, commonly known as guggul, is a tree whose oleo-gum resin is used in traditional Ayurvedic, Siddha, and Unani medicine for treating obesity, inflammation, and lipid disorders [PMID:29746995, PMID:26587309].
Background
Commiphora wightii (syn. Commiphora mukul) is a plant native to the dry regions of India (specifically Gujarat, Rajasthan, and Madhya Pradesh) and bordering regions of Pakistan [PMID:26587309, PMID:23716870]. The medicinal part is an oleo-gum resin tapped from incisions made in the bark [PMID:26587309].
Traditional uses
Traditionally used in Ayurveda for centuries to treat obesity, liver disorders, internal tumors, malignant sores, ulcers, urinary complaints, intestinal worms, leucoderma, sinus, edema, sudden paralytic seizures, inflammation, gout, and rheumatism [PMID:26561056, PMID:26587309, PMID:27771932].
Active compounds
The primary bioactive constituents are the plant sterol isomers E- and Z-guggulsterone [PMID:12626688, PMID:32110820]. Other identified metabolites include amino acids, fatty acids, organic acids, phenolic acids, pregnane-derivatives, steroids, sterols, sugars, sugar alcohols, terpenoids, tocopherol, quinic acid, and myo-inositol [PMID:25561401, PMID:26587309].
Mechanism of action
Guggulsterones act as antagonist ligands for the farnesoid X receptor (FXR), which regulates bile acid and cholesterol homeostasis [PMID:12626688, PMID:27771932]. They also modulate gene expression by regulating transcription factors such as NF-kappaB, STAT-3, and C/EBPalpha, and downregulating anti-apoptotic proteins (e.g., Bcl-2, survivin) and cell cycle proteins (cyclin D1, c-Myc) [PMID:26561056, PMID:27771932, PMID:19189646].
Clinical evidence
Evidence AHyperlipidemia
Systematic review and other studies indicate significant decreases in total cholesterol and LDL cholesterol [PMID:20858178, PMID:16338199], although some data in Western populations show modest or inconsistent results [PMID:19114224, PMID:37300664].
Evidence CCancer/Tumors
Guggulsterone inhibits the growth of various tumor cells, induces apoptosis, and suppresses osteosarcoma progression by inhibiting glycolysis via the MAPK signaling pathway [PMID:26561056, PMID:40517691].
Evidence CInflammation/Arthritis
Used for treating inflammation, rheumatism, and joint disorders [PMID:32110820, PMID:26587309].
Evidence summary
The evidence for lipid-lowering effects is supported by systematic reviews and clinical trials, though results vary by population. Anti-cancer and anti-inflammatory claims are largely supported by in vitro, animal models, and review articles.
PubMed sources
1.PMID: 29746995 (2018) — Rising trade, declining stocks: The global gugul (Commiphora wightii) trade. · Journal of ethnopharmacology
2.PMID: 26561056 (2016) — Guggulsterone for Chemoprevention of Cancer. · Current pharmaceutical design
3.PMID: 25561401 (2015) — Metabolic profiling of Commiphora wightii (guggul) reveals a potential source for pharmaceuticals and nutraceuticals. · Phytochemistry
4.PMID: 12626688 (2003) — GUGULIPID: a natural cholesterol-lowering agent. · Annual review of nutrition
5.PMID: 18078436 (2007) — Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 32110820 (2020) — Guggulipid: A Promising Multi-Purpose Herbal Medicinal Agent. · Drug research
7.PMID: 16338199 (2005) — Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration. · Complementary therapies in medicine
8.PMID: 19114224 (2009) — Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia? A randomized, controlled study. · Complementary therapies in medicine
9.PMID: 23716870 (2012) — Comparative Study of Hypolipidemic Profile of Resinoids of Commiphora mukul/Commiphora wightii from Different Geographical Locations. · Indian journal of pharmaceutical sciences
10.PMID: 40517691 (2025) — Guggulsterone suppresses osteosarcoma progression by inhibiting glycolysis through MAPK signaling pathway. · Phytomedicine : international journal of phytotherapy and phytopharmacology
11.PMID: 27771932 (2016) — Guggulsterone and Its Role in Chronic Diseases. · Advances in experimental medicine and biology
13.PMID: 26587309 (2015) — Pharmacology and Phytochemistry of Oleo-Gum Resin of Commiphora wightii (Guggulu). · Scientifica
14.PMID: 26664894 (2015) — Role of Nutraceuticals in Hypolipidemic Therapy. · Frontiers in cardiovascular medicine
15.PMID: 37300664 (2023) — Supplements for Lipid Lowering: What Does the Evidence Show? · Current cardiology reports
16.PMID: 20858178 (2010) — The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review. · Current pharmaceutical design
17.PMID: 37196815 (2023) — Protective effect of oleo-gum resin of Commiphora wightii against elastase-induced chronic obstructive pulmonary disease-linked lung inflammation and emphysema: Isolation and identification of key bioactive phytoconstituent. · Journal of ethnopharmacology
18.PMID: 35152549 (2022) — Standardization and validation of phytometabolites by UHPLC and high-performance thin layer chromatography for rapid quality assessment of ancient ayurvedic medicine, Mahayograj Guggul. · Journal of separation science
19.PMID: 19189646 (2008) — The guggul for chronic diseases: ancient medicine, modern targets. · Anticancer research